Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic ...

Bacillus subtilis has emerged as a pre‐eminent model organism for the study and application of protein expression and secretion, owing to its robust secretory pathways and genetic tractability. Its ...

Escherichia coli remains at the forefront of recombinant protein production, owing to its rapid growth, well-characterised genetics and the ease with which it can be genetically manipulated. The ...

Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...

The cost-effective, easy-to-use T7 expression system has been integral to Escherichia coli protein production since its introduction in 1986. Now, a just-developed enhancement is making it even better ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

Inside the race to turn one of cell biology’s least understood processes into a new foundation for drug development and ...

By combining Transformer-based sequence modeling with a novel conditional probability strategy, the approach overcomes ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).